849-P: Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of an Optimized Dual GLP-1/GIP Receptor Agonist (BGM0504) in Healthy Subjects—A Phase Ia, Randomized, Double-Blind, Placebo-Controlled, Ascending Dose Study
用户TBS_MGy5GuJQ
1个月前
160
10
已完结
1. 系统已在2025-07-15 09:44:56对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.2337/db24-849-p
其他信息:
出版社: American Diabetes Association
作者: JIANDONG YUAN; YANGQING HUANG; HAIFENG DING; XIAOHUI JIANG
全文下载地址: https://diabetesjournals.org/diabetes/article/73/Supplement_1/849-P/156353/849-P-Safety-Tolerability-Pharmacokinetics-PK-and
